{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:26:11Z","timestamp":1787667971934,"version":"build-2736575974"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The senescence-associated secretory phenotype (SASP) represents a complex and dynamic collection of bioactive factors secreted by senescent cells, which exerts dual regulatory effects on breast cancer (BC) progression. When SASP is transiently expressed, it promotes tumor suppression by recruiting immune cells to enhance immunosurveillance against senescent cells, and by transmitting paracrine signals that inhibit cancer cell proliferation. In contrast, when senescent cells cannot be cleared in a timely manner and SASP transitions to a chronic, persistent state, it drives tumor progression through multiple mechanisms, including the promotion of chronic inflammation, induction of epithelial-to-mesenchymal transition (EMT), and facilitation of immune evasion. Unlike previous pan-cancer reviews that largely rely on descriptive literature summaries, this review focuses specifically on BC and integrates pathogenic mechanism analysis with inter-subtype comparisons across BC subtypes. The dual roles of SASP in BC are systematically examined along three dimensions: cellular origin, temporal dynamics, and SASP component heterogeneity. Furthermore, existing SASP-targeted therapeutic strategies are discussed, with the aim of providing novel insights into the potential role of SASP in BC treatment.<\/jats:p>","DOI":"10.3389\/fonc.2026.1853883","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:42:55Z","timestamp":1787665375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The double-edged sword of SASP in breast cancer: from tumor suppression to progression and therapy resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Xianneng","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiefeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, Hainan Affiliated Hospital of Hainan Medical University (Hainan General Hospital)","place":["Haikou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2611203","article-title":"The gut microbiota-obesity axis in the pathogenesis and prognosis of breast cancer","volume":"58","author":"Zhang","year":"2026","journal-title":"Ann Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1007\/s11357-024-01384-w","article-title":"Senescence-related genes as prognostic indicators in breast cancer survival","volume":"47","author":"Ungvari","year":"2025","journal-title":"Geroscience"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0172-3","article-title":"Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence\/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line","volume":"15","author":"Ortiz-Montero","year":"2017","journal-title":"Cell Commun Signal"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj5705","article-title":"TSPAN8+ myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Sci Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00262-024-03695-5","article-title":"Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells","volume":"73","author":"Favaretto","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13058-025-02072-z","article-title":"MSN\/STAT3 drives cancer stemness and chemoresistance via IL-6\/LPAR1 ligand receptor complex in triple-negative breast cancer","volume":"27","author":"Lee","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073950","article-title":"Tumor cell-associated IL-1\u03b1 affects breast cancer progression and metastasis in mice through manipulation of the tumor immune microenvironment","volume":"25","author":"Krishnamohan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005543","article-title":"Anti-TGF-\u03b2\/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer","volume":"10","author":"Yi","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15117","DOI":"10.1038\/s41598-024-65821-8","article-title":"Impending role of inflammatory markers and their specificity and sensitivity in breast cancer patients","volume":"14","author":"Malik","year":"2024","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.02.012","article-title":"Integrin beta 3 regulates cellular senescence by activating the TGF-\u03b2 pathway","volume":"18","author":"Rapisarda","year":"2017","journal-title":"Cell Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-02973-x","article-title":"Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence","volume":"43","author":"Reid","year":"2024","journal-title":"Oncogene"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2025.101148","article-title":"Kv11.1-dependent senescence activates a lethal immune response via tumor necrosis factor alpha","volume":"63","author":"Saatloo","year":"2025","journal-title":"Neoplasia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13070801","article-title":"CCL2 and lactate from chemotherapeutics-treated fibroblasts drive Malignant traits by metabolic rewiring in low-migrating breast cancer cell lines","volume":"13","author":"Vera","year":"2024","journal-title":"Antioxid (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.972383","article-title":"CCL5 mediates breast cancer metastasis and prognosis through CCR5\/Treg cells","volume":"12","author":"Qiu","year":"2022","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.62347\/UAIS7070","article-title":"The Zeb1-Cxcl1 axis impairs the antitumor immune response by inducing M2 macrophage polarization in breast cancer","volume":"14","author":"Ou","year":"2024","journal-title":"Am J Cancer Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14820","article-title":"Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR-6838-5p","volume":"14","author":"Zhang","year":"2023","journal-title":"Thorac Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156309","article-title":"Multi-dimensional targeting of the tumor microenvironment to inhibit the invasion and metastasis of breast cancer","volume":"277","author":"Wang","year":"2026","journal-title":"Pathol Res Pract"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-021-01044-2","article-title":"FGF exhibits an important biological role on regulating cell proliferation of breast cancer when it transports into the cell nuclei","volume":"80","author":"Gao","year":"2022","journal-title":"Cell Biochem Biophys"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2021.06.002","article-title":"Downregulation of PDGF-D inhibits proliferation and invasion in breast cancer MDA-MB-231 cells","volume":"22","author":"Lu","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI145296","article-title":"Breast cancer-derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironment","volume":"131","author":"Su","year":"2021","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12964-024-01861-x","article-title":"Senescent cells promote breast cancer cells motility by secreting GM-CSF and bFGF that activate the JNK signaling pathway","volume":"22","author":"Wang","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/biology13090654","article-title":"Inflammation and tumor progression: the differential impact of SAA in breast cancer models","volume":"13","author":"Olivier","year":"2024","journal-title":"Biol (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001966","article-title":"Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"9","author":"Hubert","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3892\/ol.2025.15338","article-title":"Cellular senescence in cancer: unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (review)","volume":"30","author":"Lam","year":"2025","journal-title":"Oncol Lett"},{"key":"B27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12943-025-02475-8","article-title":"The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy","volume":"24","author":"Cao","year":"2025","journal-title":"Mol Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061860","article-title":"Detection of cellular senescence reveals the existence of senescent tumor cells within invasive breast carcinomas and related metastases","volume":"15","author":"Cotarelo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1191910","article-title":"A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0426","article-title":"Senescent CAFs mediate immunosuppression and drive breast cancer progression","volume":"14","author":"Ye","year":"2024","journal-title":"Cancer Discov"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1727142","article-title":"Research progress on the spatiotemporal dynamics of therapy-induced senescence in remodeling the tumor microenvironment","volume":"17","author":"Zhao","year":"2026","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3397","article-title":"NOTCH1 mediates a switch between two distinct secretomes during senescence","volume":"18","author":"Hoare","year":"2016","journal-title":"Nat Cell Biol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Dong","year":"2024","journal-title":"Mol Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.32604\/or.2023.044775","article-title":"Metochalcone induces senescence-associated secretory phenotype via JAK2\/STAT3 pathway in breast cancer","volume":"32","author":"Zhou","year":"2024","journal-title":"Oncol Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-024-10710-w","article-title":"A senescence-associated secretory phenotype of bone marrow mesenchymal stem cells inhibits the viability of breast cancer cells","volume":"20","author":"Li","year":"2024","journal-title":"Stem Cell Rev Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.674354","article-title":"Senescence-induced chemoresistance in triple negative breast cancer and evolution-based treatment strategies","volume":"11","author":"Chakrabarty","year":"2021","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression","volume":"5","author":"Copp\u00e9","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13632","article-title":"NF-\u03baB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cells","volume":"21","author":"Raynard","year":"2022","journal-title":"Aging Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2021.1609795","article-title":"Immunohistochemical expressions of senescence-associated secretory phenotype and its association with immune microenvironments and clinicopathological factors in invasive breast cancer","volume":"27","author":"Park","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s42003-023-05433-6","article-title":"Cellular senescence triggers intracellular acidification and lysosomal pH alkalinized via ATP6AP2 attenuation in breast cancer cells","volume":"6","author":"Li","year":"2023","journal-title":"Commun Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13402-026-01197-3","article-title":"Targeting senescence-like tumor-associated macrophages sensitizes chemotherapy in triple-negative breast cancer","volume":"49","author":"Zhou","year":"2026","journal-title":"Cell Oncol (Dordr)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112129","article-title":"TGF-\u03b2 in the microenvironment induces a physiologically occurring immune-suppressive senescent state","volume":"42","author":"Matsuda","year":"2023","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108438","article-title":"Melatonin-mediated cGAS-STING signal in senescent macrophages promote TNBC chemotherapy resistance and drive the SASP","volume":"301","author":"Zhang","year":"2025","journal-title":"J Biol Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"16106","DOI":"10.1038\/s41598-026-47488-5","article-title":"Deruxtecan-based antibody-drug-conjugates induce senescence in HER2-positive breast cancer","volume":"16","author":"Vezzoli","year":"2026","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-23-0051","article-title":"Senescence and immunotherapy: redundant immunomodulatory pathways promote resistance","volume":"11","author":"Oesterreich","year":"2023","journal-title":"Cancer Immunol Res"},{"key":"B46","article-title":"Small molecule activators of the mitochondrial protease ClpP induce senescence in triple-negative breast cancer cells and sensitize cells to the Bcl-2 inhibitor venetoclax [Preprint]","volume-title":"Res Sq.","author":"Daglish","year":"2025"},{"key":"B47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s44446-025-00034-2","article-title":"Talazoparib and radiation enhance the senolytic efficacy of venetoclax in therapy-induced senescent triple-negative breast cancer cells","volume":"33","author":"Almudimeegh","year":"2025","journal-title":"Saudi Pharm J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0787","article-title":"Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer","volume":"82","author":"Duro-S\u00e1nchez","year":"2022","journal-title":"Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01923-y","article-title":"Cellular senescence and senolytics: the path to the clinic","volume":"28","author":"Chaib","year":"2022","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13541","article-title":"CDK4\/6 inhibitors induce breast cancer senescence with enhanced anti-tumor immunogenic properties compared with DNA-damaging agents","volume":"18","author":"Lee","year":"2024","journal-title":"Mol Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s43440-025-00721-w","article-title":"Chalcone-9: a novel inhibitor of the JAK-STAT pathway with potent anti-cancer effects in triple-negative breast cancer cells","volume":"77","author":"Lee","year":"2025","journal-title":"Pharmacol Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1038\/s41598-026-38465-z","article-title":"Safety and preliminary efficacy of adding tocilizumab to cisplatin\/docetaxel for the treatment of locally advanced triple-negative breast cancer patients: prospective phase 1\/2 clinical trial","volume":"16","author":"Al-Tweigeri","year":"2026","journal-title":"Sci Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1101\/gad.262642.115","article-title":"Inhibition of the autocrine IL-6-JAK2-STAT3-calprotectin axis as targeted therapy for HR-\/HER2+ breast cancers","volume":"29","author":"Rodriguez-Barrueco","year":"2015","journal-title":"Genes Dev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205789","article-title":"Cell type-dependent modulation of senescence features using Weo electrolyzed water","volume":"16","author":"Court-Vazquez","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030605","article-title":"Senolysis-based elimination of chemotherapy-induced senescent breast cancer cells by quercetin derivative with blocked hydroxy groups","volume":"14","author":"Lewi\u0144ska","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","article-title":"A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues","volume":"13","author":"Saul","year":"2022","journal-title":"Nat Commun"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1853883\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T13:42:57Z","timestamp":1787665377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1853883\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":56,"alternative-id":["10.3389\/fonc.2026.1853883"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1853883","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1853883"}}